Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 4:07 PM
Ignite Modification Date:
2025-12-25 @ 2:08 PM
NCT ID:
NCT00413166
Pre Assignment Details:
Pfizer withdrew gemtuzumab ozogamycin (GO) from market based Food \& Drug Administration recommendation. As such, protocol modified to Idarubicin Day 1 of induction in high-risk participants \& in low risk participants with rising white blood count (WBC), Idarubicin administered to low-risk patients in whom WBC \>10,000 after initiation of ATRA + ATO.
Recruitment Details:
Recruitment Period: December 5, 2006 to April 3, 2012. All recruitment done at The University of Texas MD Anderson Cancer Center.
Study:
NCT00413166
Study Brief:
Results Section:
NCT00413166